A control system for a cardiopulmonary resuscitation device has been registered at Penza State University. The adaptive system continuously gathers patient data during resuscitation and drives chest compressions with adjustable frequency and depth, aiming to maintain effective circulation until standard care is restored. The ministry overseeing education in Russia disclosed this development to socialbites.ca.
A cardiopulmonary resuscitation device is employed in cases of cardiac arrest to restart the heart and restore blood flow throughout the body. The device is designed to take over the manual effort of a healthcare professional during resuscitation, delivering uninterrupted automatic chest compressions at a preset pace and compression depth. It monitors breathing and circulation, and, as stated by the program’s developer, Kirill Ilyin, it can initiate chest compressions, artificial respiration, and advanced therapy if a critical situation is detected.
For reliable operation, the system tracks key patient parameters such as sternum movement, compression frequency, carbon dioxide levels during exhalation, pulse rate, and other indicators throughout the resuscitation process. These metrics are managed by a control program that runs on a tachometer assembled by PSU researchers. Mounted on the device body, the tachometer measures how often the device compresses the chest per minute.
“The prototype acts as a tachometer whose control program forms the device’s brain, tuned to respond to specific emergency scenarios and govern the compression rate accordingly,” explains Ilyin. “We taught it algorithms that enable it to deliver appropriate emergency care when every second counts.”
When necessary, the program can wirelessly transmit collected information to the hospital staff awaiting the patient. This capability supports rapid, coordinated care in the field and helps prepare the receiving facility for immediate intervention, whether on the scene or during transport by ambulance to the hospital for possible surgical procedures.
Earlier research in Russia explored natural glass analogues used for targeted drug delivery, illustrating an ongoing commitment to advancing biomedical devices and patient support technologies across medical disciplines.